Company / Net Income
CRESCENT BIOPHARMA, INC. Net Income History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$153.9M
FY2025
5-year range
-$153.9M / $3.7M
FY2021-FY2025
Trend
-1105.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income changed -1106% YoY in FY2025, a notable deviation from the 4-year average annual change of -379%.
Based on SEC 10-K filings.
-$154M in FY2025.
Declined from -$11M to -$154M over the past 9 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- CRESCENT BIOPHARMA, INC.'s net income has declined for 4 consecutive years.
- In FY2025, net income decreased 1105.5% year-over-year.
- Peak net income was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$153.9M | -1105.5% |
| FY2017 | -$12.8M | -14.8% |
| FY2016 | -$11.1M | -4.9% |
| FY2015 | -$10.6M | -390.1% |
| FY2014 | $3.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026